K. Horton

Dapagliflozin: A Newly Approved SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

CE Included, Ann Marie Ruhe, E. Blum, 2014 .

A Comparison of Mipomersen (Kynamro®) and Lomitapide (Juxtapid®): Medications for the Treatment of Homozygous Familial Hypercholesterolemia CE Included

Austin J. Brown, E. Blum, K. Horton, 2014 .

Medication Overdoses in the Emergency Department: Oral Hypoglycemic Agents, Atypical Antipsychotic Agents, Beta-Blockers, Calcium Channel Blockers, and Digoxin CE Included Brooke Marlowe, fourth-year pharmacy student from Granville, Ohio; Tara Tokar, fifth-year pharmacy student from Dayton, Ohio; Ka

N. Dipietro, K. Kier, E. Blum, 2014 .

Accountable Care Organizations: What Pharmacists Should Know

K. Horton, D. Sullivan, Rachel J. Pucel, 2013 .

Neonatal Abstinence Syndrome: A Targeted Review for Pharmacists CE Included

G. Walliser, K. Horton, Maria Laikos, 2014 .

Sildenafil as an Appropriate Monotherapy Option in the Treatment of Pulmonary Arterial Hypertension (PAH)

K. Horton, S. Ginty, 2020 .